Interax

InterAx Biotech AG Sets an Industry Example in Better Understanding Disease Biology and Reducing Candidate Drug Risks. By not only utilizing machine learning algorithms to harness vast amounts of data but also integrating critical biological knowledge of fundamental systems into intelligent drug discovery algorithms. The company's rigorous, bottom-up understanding of target systems represents an important milestone on the path to the rational design of effective and safe candidate drugs.